Anti-tumour necrosis factor-α activity in Ixodes ricinus saliva

Parasite Immunology

Volumn 28, Issue 12, 2006, Pages 649-656

  Konik P ^a,b   Slavikova V ^b   Salat J ^a,b   Reznickova J ^a,b   Dvoroznakova E ^b,c   Kopecky J ^a,b  

^a UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^b INSTITUTE OF PARASITOLOGY   (Czech Republic)

^c PARASITOLOGICAL INSTITUTE   (Slovakia)

Author keywords

Ixodes ricinus; Tick saliva; TNF

Indexed keywords

CYTOKINE; PROTEIN; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; BIOASSAY; CONTROLLED STUDY; CYTOTOXICITY; DIGESTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAST PROTEIN LIQUID CHROMATOGRAPHY; FEEDING; FEMALE; INFESTATION; IXODES RICINUS; MOLECULAR WEIGHT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; SALIVA; SALIVARY GLAND;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IXODES; MICE; SALIVA; SALIVARY GLANDS; TISSUE EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

ACARI; IXODES RICINUS; IXODIDA;

EID: 33750869782     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2006.00899.x     Document Type: Article

References (38)

1. Hajnická V, Kocáková P, Slovák M, Labuda M, Fuchsberger N & Nuttall PA. Inhibition of the antiviral action of interferon by tick salivary gland extract. Parasite Immunol 2000; 22: 201-206.
2. Ramamoorthi N, Narasimhan S, Pal U et al. Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 2005; 436: 573-577.
3. Ribeiro JMC. Ixodes dammini: salivary anti-complement activity. Exp Parasitol 1987; 64: 347-353.
4. Ribeiro JMC & Spielman A. Ixodes dammini: salivary anaphylatoxin inactivating activity. Exp Parasitol 1986; 62: 292-297.
5. Ribeiro JMC, Weiss JJ & Telford SR III. Saliva of the tick Ixodes dammini inhibits neutrophil function. Exp Parasitol 1990; 70: 382-388.
6. Urioste S, Hall LE, Telford SR III & Titus R. Saliva of the Lyme disease vector, Ixodes dammini, blocks cell activation by a nonprostaglandin E2-dependent mechanism. J Exp Med 1994; 180: 1077-1085.
7. Kopecký J & Kuthejlová M. Suppressive effect of Ixodes ricinus salivary gland extract on mechanisms of natural immunity in vitro. Parasite Immunol 1998; 20: 169-174.
8. Wikel SK. Influence of Dermacentor andersoni infestation on lymphocyte responsiveness to mitogens. Ann Trop Med Parasitol 1982; 76: 627-632.
9. Ramachandra RN & Wikel SK. Modulation of host-immune responses to ticks (Acari: Ixodidae): effect of salivary gland extracts on host macrophages and lymphocyte cytokine production. J Med Entomol 1992; 29: 818-826.
10. Kovář L, Kopecký J & Říhová B. Salivary gland extract from Ixodes ricinus ticks polarizes the cytokine profile toward Th2 and suppresses proliferation of T lymphocytes in human PBMC culture. J Parasitol 2001; 87: 1342-1348.
11. Ferreira BR & Silva JS. Successive tick infestations selectively promote a T-helper 2 cytokine profile in mice. Immunology 1999; 96: 434-439.
12. Kopecký J, Kuthejlová M & Pechová J. Salivary gland extract from Ixodes ricinus ticks inhibits production of interferon-γ by the upregulation of interleukin-10. Parasite Immunol 1999; 21: 351-356.
13. Nuttall PA & Jones LD. Non-viraemic tick-borne virus transmission: mechanisms and significance; in Dusbábek F, Bukva V (eds): Modern Acarology, Vol 2. The Hague, the Netherlands, Academia, Prague and SPB Academic Publishing bv, 1991: 3-6.
14. Labuda M & Nuttall PA, Kožuch O et al. Non-viremic transmission of tick-borne encephalitis virus. A mechanism for arbovirus survival in nature. Experientia 1993; 49: 802-805.
15. Pechová J, Štěpánová G, Kovář L & Kopecký J. Tick salivary gland extract-activated transmission of Borrelia afzelii spirochaetes. Folia Parasitol 2002; 49: 153-159.
16. Kročová Z, Macela A, Hernychová L, Kroča M, Pechová J, Kopecký J. Tick salivary gland extract accelerates proliferation of Franciscella tularensis in the host. J Parasitol 2003; 89: 14-20.
17. Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rew 2003; 14: 185-191.
18. Gwakisa P, Yoshihara K, Long To T, Gotoh H, Amano F & Momotani E. Salivary gland extract of Rhipicephalus appendiculatus ticks inhibits in vitro transcription and secretion of cytokines and production of nitric oxide by LPS-stimulated JA-4 cells. Vet Parasitol 2001; 99: 53-61.
19. Gillespie RD, Dolan MC, Piesman J & Titus RG. Identification of an IL-2 binding protein in the saliva of the Lyme disease vector tick Ixodes scapularis. J Immunol 2001; 166: 4319-4327.
20. Hajnická V, Kocáková P, Sláviková M et al. Anti-interleukin-8 activity of tick salivary gland extracts. Parasite Immunol 2001; 23: 483-489.
21. Hehlgans T & Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005; 115: 1-20.
22. Chinnaiyan AM, Tepper CG, Seldin MF et al. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996; 271: 4961-4965.
23. Ferreira BR, Szabo MJ, Cavassani KA, Bechara GH & Silva JS. Antigens from Rhipicephalus sanguineus ticks elicit potent cell-mediated immune responses in resistant but not in susceptible animals. Vet Parasitol 2003; 115: 35-48.
24. Sheikh NA, Caro HN, Taverne J, Playfair JH & Rademacher TW. Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes. Immunology 1996; 87: 461-466.
25. Saraiva M & Alcami A. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J Virol 2001; 75: 226-233.
26. Brunetti CR, Paulose-Murphy M, Singh R et al. A secreted high-affinity inhibitor of human TNF from Tanapox virus. Proc Natl Acad Sci USA 2003; 100: 4831-4836.
27. Upton C, Macen JL, Schreiber M & McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 1991; 184: 370-382.
28. Hajnická V, Vaněová I, Kocáková P et al. Manipulation of host cytokine network by ticks: potential gateway for pathogen transmission. Parasitology 2005; 130: 333-342.
29. Wang H & Nuttall PA. Immunoglobulin binding proteins in ticks: new target for vaccine development against a bloodfeeding parasite. Cell Molecul Life Sci 1999; 56: 286-295.
30. Dempsey PW, Doyle SE, He JQ & Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003; 14: 193-209.
31. Cumberbatch M & Kimber I. Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 1995; 84: 31-35.
32. Nawroth PP & Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740-745.
33. Sjostedt A, North RJ & Conlan JW. The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum. Microbiology 1996; 142: 1369-1374.
34. Sjowall J, Carlsson A, Vaarala O et al. Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes. Clin Exp Immunol 2005; 141: 89-98.
35. Zeidner N, Dreitz M, Belasco D & Fish D. Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumour necrosis factor-α, interleukin-2 and interferon-γ J Infect Dis 1996; 173: 187-195.
36. Lewis M, Tartaglia LA, Lee A et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 1991; 88: 2830-2834.
37. Montgomery RR, Lusitani D, de Boisfleury Chevance A & Malawista SE. Tick saliva reduces adherence and area of human neutrophils. Infect Immun 2004; 72: 2989-2994.
38. Severinová J, Salát J, Kročová Z et al. Co-inoculation of Borrelia afzelii with tick salivary gland extract influences distribution of immunocompetent cells in the skin and lymph nodes of mice. Folia Microbiol 2005; 50: 457-463.